Gemtide Teriparatide Injection

Gemtide Teriparatide Injection Specification

Life Span
36 months from date of manufacture

Brand Name
Gemtide

Dosage Form
Solution for injection

Salt Composition
Teriparatide (Recombinant) 750 mcg

Indication
Osteoporosis, high-risk fracture prevention

Packaging Type
Prefilled pen

Pacakaging (Quantity Per Box)
1 prefilled pen per box

Origin of Medicine
India

Drug Type
Injection

Ingredients
Teriparatide (Recombinant) 750 mcg / 3 ml

Physical Form
Liquid

Function
Bone formation, osteoporosis treatment

Recommended For
Patients with osteoporosis at high risk of fracture

Dosage
20 mcg (0.08 ml) once daily

Dosage Guidelines
As per the doctor's advice

Suitable For
Adults

Quantity
750 mcg / 3 ml prefilled pen

Storage Instructions
Keep at cool and Dry Place

Regulatory Approval
DCGI approved

Prescription Required
Yes

Special Precautions
Not recommended for children or young adults with open epiphyses

Color
Clear, colorless solution

Administration Route
Subcutaneous injection (thigh or abdomen)

Common Side Effects
Nausea, headache, leg cramps, dizziness

Maximum Shelf Life After Opening
Use within 28 days after first use

Patient Guidance
Do not use if solution is cloudy or contains particles

Gemtide Teriparatide Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Paypal, Cash Advance (CA), Cheque

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Gemtide Teriparatide Injection

Gemtide Teriparatide Injection is a medication used in the treatment of osteoporosis. Teriparatide is the recombinant form of human parathyroid hormone, specifically the N-terminal fragment (amino acids 1-34). It contains the active ingredient Teriparatide, which is a synthetic form of parathyroid hormone (PTH). This is used to treat osteoporosis in postmenopausal women and men who are at high risk of fractures. Teriparatide stimulates bone formation by promoting the activity of osteoblasts (cells responsible for bone formation) and increasing bone mineral density. Gemtide Teriparatide Injection is also indicated for the treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture.

Specification

Also Gives	PCD Pharma Franchise
Composition	Teriparatide 600mcg
Country of Origin	Made In India
Packaging Size	2.4ml
Prescription/Non-Prescription	Non-Prescription
Shelf Life	24 Months
Strength	600 mcg

How Gemtide Teriparatide Injection Works

Gemtide Teriparatide Injection stimulates new bone formation by mimicking the action of parathyroid hormone, leading to increased bone density. It is particularly beneficial for adults with osteoporosis who are at high risk of fractures. The injection assists in strengthening the skeleton, thus decreasing the likelihood of future bone injuries.

Correct Usage and Administration

This injection is administered subcutaneously, typically into the thigh or abdomen, as directed by your doctor. Always use a new needle for each injection, and never use the solution if it appears cloudy or contains particles. Follow your doctor's guidance regarding dosage and timing for optimal results.

Storage and Shelf Life Details

Gemtide should be kept in a cool, dry place, away from direct sunlight. The prefilled pen must be used within 28 days of first opening, and unused pens should not be stored beyond the expiry mentioned (36 months from manufacture). Proper storage maintains the efficacy of the medication.

FAQ's of Gemtide Teriparatide Injection:

Q: How should Gemtide Teriparatide Injection be administered?

A: Gemtide Teriparatide is administered by injecting it subcutaneously into the thigh or abdomen, following your doctor's instructions. Rotate injection sites to minimize irritation.

Q: What are the storage requirements for Gemtide Teriparatide Injection?

A: Store the prefilled pen in a cool, dry place, and never use it if the solution appears cloudy or contains any particles. Dispose of the pen 28 days after first use, even if some solution remains.

Q: Who can use Gemtide Teriparatide Injection?

A: This medication is recommended for adult patients with osteoporosis at high risk of fracture. It is not suitable for children or young adults with open epiphyses.

Q: What are the benefits of using Gemtide Teriparatide Injection?

A: Gemtide Teriparatide promotes bone formation, increasing bone density and reducing the risk of fractures in patients with severe osteoporosis.

Q: What precautions should I follow when using Gemtide Teriparatide Injection?

A: Do not use the injection if the solution is cloudy or contains visible particles. Always follow your doctor's prescribed dosage and avoid use in children or in young adults who have open bone growth plates.

Q: What side effects might occur with Gemtide Teriparatide Injection?

A: Some patients may experience nausea, headache, leg cramps, or dizziness. If these or other unusual symptoms occur, consult your healthcare provider promptly.